Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Capital Expenditures: 2021-2024

Historic Capital Expenditures for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $10,000.

  • Biofrontera's Capital Expenditures was N/A to -$1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$37,000, marking a year-over-year change of. This contributed to the annual value of $10,000 for FY2024, which is 100.00% up from last year.
  • Latest data reveals that Biofrontera reported Capital Expenditures of $10,000 as of FY2024, which was up 100.00% from $5,000 recorded in FY2023.
  • Biofrontera's Capital Expenditures' 5-year high stood at $38,000 during FY2022, with a 5-year trough of $5,000 in FY2023.
  • In the last 3 years, Biofrontera's Capital Expenditures had a median value of $10,000 in 2024 and averaged $17,667.
  • As far as peak fluctuations go, Biofrontera's Capital Expenditures skyrocketed by 245.45% in 2022, and later tumbled by 86.84% in 2023.
  • Biofrontera's Capital Expenditures (Yearly) stood at $11,000 in 2021, then surged by 245.45% to $38,000 in 2022, then plummeted by 86.84% to $5,000 in 2023, then spiked by 100.00% to $10,000 in 2024.